Back to companies
Aurinia Pharmaceuticals Inc.
AUPHCANASDAQPharmaceuticals & HealthcareAurinia Pharmaceuticals Inc.
Revenue
$283.1mn
YoY +20.4%
Operating income
$104.9mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API